Authors : Mahesh Chandra
DOI : 10.31579/2835-2882/062
Volume : 3
Issue : 4
Year : 2024
Page No : 01-08
Lupus is a systemic chronic inflammatory autoimmune disease that can present with a wide range of clinical symptoms. The four main types of lupus are neonatal and paediatric lupus erythematosus (NLE), drug induced lupus (DIL), discoid lupus erythematosus (DLE) and systemic lupus erythematosus (SLE). Due to aberrant immunological function and the generation of autoantibodies, which result in the development of immune complexes that may negatively impact healthy tissue, patients with lupus have a loss of self-tolerance. Immune abnormalities, environmental, hormonal, and genetic variables have been discovered, but the exact etiologic process remains unknown. There have also been confirmed correlations between the start of lupus and age, sex, region, and race. Microbiological and pharmaceutical methods for symptoms reduction, resolution, and enhanced quality of life should be part of the personalized management of this illness.